EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation Between Regulator T Cell Levels and Acetylcholine Receptor Antibody Levels and Clinical in Patients with Myasthenia Gravis

Elta-Diah Pasmanasari, William Tanyawan, Dodik-Tugasworo Pramukarso, Retnaningsih Retnaningsih, Jimmy-Eko-Budi Hartono, Suryadi Suryadi

Biomedical & Pharmacology Journal · 21.03.2026 · 1 (19) · 545

DOI: 10.13005/bpj/3373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 20.03.2026. Verfasst von Elta-Diah Pasmanasari und 5 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myasthenia Gravis (MG) is an autoimmune disease characterized by muscle weakness due to disorders of the neuromuscular junction. Most patients with Myasthenia gravis have autoantibodies against acetylcholine receptors (AChR). Regulatory T cells (Tregs) are thought to be involved in the pathophysiology of MG, where they influence the maturation and proliferation of B cells (both in the thymus and peripherally). This showed that Tregs play a significant role in the production of autoantibodies in MG disease. The study aims to analyze the correlation among Treg levels, AChR levels, and clinical severity in patients with myasthenia gravis. This is a descriptive analytical study with a cross-sectional design. Outpatients with Myasthenia Gravis in Dr. Kariadi General Hospital in Semarang who met the inclusion and exclusion criteria had their blood drawn and demographic data collected through the electronic medical record. The Treg level was measured by flow cytometry, and the antibody level was measured by ELISA. The correlation between Treg and AChR levels was analysed using the Spearman test, and the association between Treg levels and clinical severity was analysed using the Mann-Whitney test. The research results show a significant, weakly correlated inverse relationship between Treg cell levels and AChR antibodies. (p = 0.049, r = -0.406) and has no significant association with MGFA-PIS score (p = 0,427)

Zitieren

APA

Pasmanasari, E., Tanyawan, W., Pramukarso, D., Retnaningsih, R., Hartono, J., & Suryadi, S. (2026). Correlation Between Regulator T Cell Levels and Acetylcholine Receptor Antibody Levels and Clinical in Patients with Myasthenia Gravis. Biomedical & Pharmacology Journal, 1(19), 545. https://doi.org/10.13005/bpj/3373

Vancouver

Pasmanasari E, Tanyawan W, Pramukarso D, Retnaningsih R, Hartono J, Suryadi S. Correlation Between Regulator T Cell Levels and Acetylcholine Receptor Antibody Levels and Clinical in Patients with Myasthenia Gravis. Biomedical & Pharmacology Journal. 2026;1(19):545. doi:10.13005/bpj/3373

BibTeX
@article{Pasmanasari2026,
  author = {Pasmanasari, Elta-Diah and Tanyawan, William and Pramukarso, Dodik-Tugasworo and Retnaningsih, Retnaningsih and Hartono, Jimmy-Eko-Budi and Suryadi, Suryadi},
  title = {Correlation Between Regulator T Cell Levels and Acetylcholine Receptor Antibody Levels and Clinical in Patients with Myasthenia Gravis},
  journal = {Biomedical & Pharmacology Journal},
  year = {2026},
  volume = {1},
  number = {19},
  pages = {545},
  doi = {10.13005/bpj/3373}
}
Kostenlos starten →